479 related articles for article (PubMed ID: 32059825)
21. Menopausal hormonal therapy in gynaecological cancers: An evidence-based approach for clinical management.
Fenton CL; McGauran MJ; Richards AM
Aust N Z J Obstet Gynaecol; 2020 Dec; 60(6):942-945. PubMed ID: 32815168
[TBL] [Abstract][Full Text] [Related]
22. Management of menopausal symptoms in women with gynecologic cancers.
Del Carmen MG; Rice LW
Gynecol Oncol; 2017 Aug; 146(2):427-435. PubMed ID: 28625396
[TBL] [Abstract][Full Text] [Related]
23. Global consensus statement on menopausal hormone therapy.
de Villiers TJ; Gass ML; Haines CJ; Hall JE; Lobo RA; Pierroz DD; Rees M
Climacteric; 2013 Apr; 16(2):203-4. PubMed ID: 23488524
[TBL] [Abstract][Full Text] [Related]
24. Effects of bilateral salpingo-oophorectomy on menopausal symptoms and sexual functioning among women with a BRCA1 or BRCA2 mutation.
Hall E; Finch A; Jacobson M; Rosen B; Metcalfe K; Sun P; Narod SA; Kotsopoulos J
Gynecol Oncol; 2019 Jan; 152(1):145-150. PubMed ID: 30414741
[TBL] [Abstract][Full Text] [Related]
25. Menopause and hormone replacement therapy: the 2017 Recommendations of the Italian Menopause Society.
Gambacciani M; Biglia N; Cagnacci A; Caruso S; Cicinelli E; DE Leo V; DI Carlo C; Farris M; Gambera A; Guaschino S; Lanzone A; Paoletti AM; Russo N; Vicariotto F; Villa P; Volpe A;
Minerva Ginecol; 2018 Feb; 70(1):27-34. PubMed ID: 28975776
[TBL] [Abstract][Full Text] [Related]
26. Demographic characteristics and medical aspects of menopausal women in Taiwan.
Chow SN; Huang CC; Lee YT
J Formos Med Assoc; 1997 Oct; 96(10):806-11. PubMed ID: 9343980
[TBL] [Abstract][Full Text] [Related]
27. Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women: US Preventive Services Task Force Recommendation Statement.
; Grossman DC; Curry SJ; Owens DK; Barry MJ; Davidson KW; Doubeni CA; Epling JW; Kemper AR; Krist AH; Kurth AE; Landefeld CS; Mangione CM; Phipps MG; Silverstein M; Simon MA; Tseng CW
JAMA; 2017 Dec; 318(22):2224-2233. PubMed ID: 29234814
[TBL] [Abstract][Full Text] [Related]
28. Menopausal hormone therapy in cancer survivors: A narrative review of the literature.
Kuhle CL; Kapoor E; Sood R; Thielen JM; Jatoi A; Faubion SS
Maturitas; 2016 Oct; 92():86-96. PubMed ID: 27621244
[TBL] [Abstract][Full Text] [Related]
29. No. 385-Indications for Pelvic Examination.
Evans D; Goldstein S; Loewy A; Altman AD
J Obstet Gynaecol Can; 2019 Aug; 41(8):1221-1234. PubMed ID: 31331610
[TBL] [Abstract][Full Text] [Related]
30. [Hormone substitution in patients after primary treatment of gynecologic malignancies].
Petru E; Lahousen M; Urdl W; Luschin G; Pickel H
Wien Med Wochenschr; 1993; 143(21):539-41. PubMed ID: 8146998
[TBL] [Abstract][Full Text] [Related]
31. Options for hormone therapy in women who have had a hysterectomy.
Haney AF; Wild RA
Menopause; 2007; 14(3 Pt 2):592-7; quiz 598-9. PubMed ID: 17476150
[TBL] [Abstract][Full Text] [Related]
32. Hormone therapy regimens for managing the menopause and premature ovarian insufficiency.
Armeni E; Paschou SA; Goulis DG; Lambrinoudaki I
Best Pract Res Clin Endocrinol Metab; 2021 Dec; 35(6):101561. PubMed ID: 34274232
[TBL] [Abstract][Full Text] [Related]
33. Should we abstain from treating women with endometriosis using menopausal hormone therapy, for fear of an increased ovarian cancer risk?
Rozenberg S; Antoine C; Vandromme J; Fastrez M
Climacteric; 2015; 18(4):448-52. PubMed ID: 25958744
[TBL] [Abstract][Full Text] [Related]
34. Risk-Reducing Bilateral Salpingo-Oophorectomy for BRCA Mutation Carriers and Hormonal Replacement Therapy: If It Should Rain, Better a Drizzle than a Storm.
Gasparri ML; Taghavi K; Fiacco E; Zuber V; Di Micco R; Gazzetta G; Valentini A; Mueller MD; Papadia A; Gentilini OD
Medicina (Kaunas); 2019 Jul; 55(8):. PubMed ID: 31362334
[TBL] [Abstract][Full Text] [Related]
35. Menopausal hormone therapy in women with benign gynaecological conditions and cancer.
Brennan A; Rees M
Best Pract Res Clin Endocrinol Metab; 2021 Dec; 35(6):101575. PubMed ID: 34686433
[TBL] [Abstract][Full Text] [Related]
36. Emerging hormonal treatments for menopausal symptoms.
Genazzani AR; Komm BS; Pickar JH
Expert Opin Emerg Drugs; 2015 Mar; 20(1):31-46. PubMed ID: 25557757
[TBL] [Abstract][Full Text] [Related]
37. Interventions to reduce the risk of ovarian and fallopian tube cancer: A European Menopause and Andropause Society Postition Statement.
Pérez-López FR; Ceausu I; Depypere H; Kehoe S; Lambrinoudaki I; Mueck A; Senturk LM; Simoncini T; Stevenson JC; Stute P; Rees M
Maturitas; 2017 Jun; 100():86-91. PubMed ID: 28389043
[TBL] [Abstract][Full Text] [Related]
38. Managing menopausal symptoms after cancer: an evidence-based approach for primary care.
Marino JL; McNamara HC; Hickey M
Med J Aust; 2018 Feb; 208(3):127-132. PubMed ID: 29438648
[TBL] [Abstract][Full Text] [Related]
39. Surgical Menopause and Bilateral Oophorectomy: Effect of Estrogen-Progesterone and Testosterone Replacement Therapy on Psychological Well-being and Sexual Functioning; A Systematic Literature Review.
Stuursma A; Lanjouw L; Idema DL; de Bock GH; Mourits MJE
J Sex Med; 2022 Dec; 19(12):1778-1789. PubMed ID: 36175351
[TBL] [Abstract][Full Text] [Related]
40. EMAS position statement: Thyroid disease and menopause.
Mintziori G; Veneti S; Poppe K; Goulis DG; Armeni E; Erel CT; Fistonić I; Hillard T; Hirschberg AL; Meczekalski B; Mendoza N; Mueck AO; Simoncini T; Stute P; van Dijken D; Rees M; Duntas L; Lambrinoudaki I
Maturitas; 2024 Jul; 185():107991. PubMed ID: 38658290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
